C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms

• Verfasst von: Nießen, Anna [VerfasserIn]
• Verfasst von: Schimmack, Simon [VerfasserIn]
• Verfasst von: Sandini, Marta [VerfasserIn]
• Verfasst von: Fliegner, Dominik [VerfasserIn]
• Verfasst von: Hinz, Ulf [VerfasserIn]
• Verfasst von: Lewosinska, Magdalena [VerfasserIn]
• Verfasst von: Hackert, Thilo [VerfasserIn]
• Verfasst von: Büchler, Markus W. [VerfasserIn]
• Verfasst von: Strobel, Oliver [VerfasserIn]
• Titel: C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms
• Verf.angabe: Anna Nießen, Simon Schimmack, Marta Sandini, Dominik Fliegner, Ulf Hinz, Magdalena Lewosinska, Thilo Hackert, Markus W. Büchler & Oliver Strobel
• E-Jahr: 2021
• Jahr: 09 December 2021
• Umfang: 11 S.
• Fussnoten: Gesehen am 15.02.2022
• Titel Quelle: Enthalten in: Scientific reports
• Ort Quelle: [London] : Macmillan Publishers Limited, part of Springer Nature, 2011
• Jahr Quelle: 2021
• Band/Heft Quelle: 11(2021), Artikel-ID 23768, Seite 1-11
• ISSN Quelle: 2045-2322
• DOI: doi:10.1038/s41598-021-03187-x
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Cancer
• Sach-SW: Medical research
• Sach-SW: Oncology
• Sach-SW: Risk factors
• K10plus-PPN: 1789619629
• K10plus-PPN:
  Universitätsbibliothek
• Lokale URL UB: Zum Volltext

Abstract

Pancreatic neuroendocrine neoplasms (pNEN) are highly variable in their postresection survival. Determination of preoperative risk factors is essential for treatment strategies. C-reactive protein (CRP) has been implicated in the pathogenesis of pNEN and shown to be associated with survival in different tumour entities. Patients undergoing surgery for pNEN were retrospectively analysed. Patients were divided into three subgroups according to preoperative CRP serum levels. Clinicopathological features, overall and disease-free survival were assessed. Uni- and multivariable survival analyses were performed. 517 surgically resected pNEN patients were analysed. CRP levels were significantly associated with relevant clinicopathological parameters and prognosis and were able to stratify subgroups with significant and clinically relevant differences in overall and disease-free survival. In univariable sensitivity analyses CRP was confirmed as a prognostic factor for overall survival in subgroups with G2 differentiation, T1/T2 and T3/T4 tumour stages, patients with node positive disease and with and without distant metastases. By multivariable analysis, preoperative CRP was confirmed as an independent predictor of postresection survival together with patient age and the established postoperative pathological predictors grading, T-stage and metastases. Preoperative serum CRP is a strong predictive biomarker for both overall and disease free survival of surgically resected pNEN. CRP is associated with prognosis independently of grading and tumour stage and may be of additional use for treatment decisions.